Matthew J. Frank

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial”.

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Nature Medicine(2021)10.1038/s41591-021-01436-0

N/A

4.8DataRank · unranked

582 citations

Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak, John H. Baird +44 more

Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial

The Journal of Experimental Medicine(2020)10.1084/jem.20191712

N/A

1.5DataRank · unranked

39 citations

Michael S. Khodadoust, Debra K. Czerwinski, Ole Audun Werner Haabeth, Michael P. Chu, David B. Miklos +19 more

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

The Lancet(2024)10.1016/s0140-6736(24)00746-3

N/A

1.4DataRank · unranked

60 citations

John H. Baird, Anne Marijn Kramer, Hrishikesh K. Srinagesh, Shabnum Patel, Annie Kathleen Brown +43 more

Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023011625

N/A

0.906DataRank · unranked

31 citations

Anna Pavlova, Robert Lowsky, Lori Muffly, Parveen Shiraz, Sally Arai +17 more

Donor regulatory T-cell therapy to prevent graft-versus-host disease

Blood(2025)10.1182/blood.2024026446

N/A

0.900DataRank · unranked

39 citations

Anna Pavlova, Alejandro Villar‐Prados, Cameron S. Bader, Bryan J. Xie, Lori Muffly +23 more

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

Nature Medicine(2022)10.1038/s41591-022-01960-7

N/A

0.828DataRank · unranked

248 citations

Jay Y. Spiegel, Bita Sahaf, Meena Malipatlolla, Zachary Ehlinger, Sreevidya Kurra +25 more

Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021004716

N/A

0.659DataRank · unranked

80 citations

Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder +16 more

A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis

Blood Advances(2023)10.1182/bloodadvances.2023011589

N/A

0.309DataRank · unranked

4 citations

Sarah Haebe, Debra K. Czerwinski, Erik Eckhert, Grady Day, Anuja Sathe +13 more

Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B‐cell lymphoma receiving immunotherapy

Cancer Cytopathology(2021)10.1002/cncy.22531

N/A

0.232DataRank · unranked

3 citations

Debra K. Czerwinski, Tanaya Shree, Matthew J. Frank, Sarah Haebe, Brock A. Martin +4 more

CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias

Research Square(2025)10.21203/rs.3.rs-7746241/v1

N/A

0.104DataRank · unranked

1 citations

Mark P. Hamilton, Nick Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio +32 more

Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009426

N/A

0DataRank · unranked

29 citations

Gregory J. Kimmel, Matthew J. Frank, Ali Bukhari, Nasheed Hossain, Michael D. Jain +5 more

Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas

Blood Advances(2023)10.1182/bloodadvances.2023011997

N/A

0DataRank · unranked

5 citations

Joseph G. Schroers‐Martin, Brian J. Sworder, Karan R. Kathuria, Stefan Alig, Matthew J. Frank +8 more

Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma

Journal of Neuropathology & Experimental Neurology(2023)10.1093/jnen/nlac121

N/A

0DataRank · unranked

10 citations

Saman Ahmadian, Sushma Bharadwaj, Lehi Acosta-Alvarez, Zachary Threlkeld, Matthew J. Frank +5 more

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Blood Advances(2021)10.1182/bloodadvances.2020002732

N/A

0DataRank · unranked

194 citations

David J. Epstein, John Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig +18 more

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Blood Advances(2024)10.1182/bloodadvances.2024012637

N/A

0DataRank · unranked

24 citations

Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani +27 more

Treatment strategies for progressive immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: case series

Haematologica(2024)10.3324/haematol.2023.284784

N/A

0DataRank · unranked

16 citations

Michael J. Eckrich, Keagan G. Lipak, Bonnie Yates, Constance M. Yuan, Hao‐Wei Wang +6 more

Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008975

N/A

0DataRank · unranked

16 citations

Eric Lau, Mark Hamilton, Anmol Goyal, Hrishi Srinagesh, Alexandria Jensen +26 more

Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.04.016

N/A

0DataRank · unranked

23 citations

Abdullah Ladha, Lori Muffly, Parveen Shiraz, Gary Goldstein, Victoria Osgood +12 more

Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies

Cytotherapy(2025)10.1016/j.jcyt.2025.09.013

N/A

0DataRank · unranked

0 citations

Anne Marijn Kramer, Bonnie Yates, Hao‐Wei Wang, Bita Sahaf, Constance M. Yuan +28 more

Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.02.026

N/A

0DataRank · unranked

9 citations

Lori Muffly, Parveen Shiraz, Judith A. Shizuru, Laura Johnston, Sally Arai +9 more

Phase 2 study of MGTA-145 + plerixafor for rapid and reliable hematopoietic stem cell (HSC) mobilization for autologous transplant in multiple myeloma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8023

N/A

0DataRank · unranked

1 citations

Andriyana K. Bankova, Hitomi Hosoya, Lori Muffly, Shaji Kumar, Laura Johnston +14 more

Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.010

N/A

0DataRank · unranked

13 citations

Juliana Craig, Stefan Torelli, Kristen Cunanan, María Iglesias, Sally Arai +14 more

Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.01.010

N/A

0DataRank · unranked

18 citations

Joseph Caveney, Bin Yao, Teresa Lopes Ramos, Jan Bögeholz, Kartoosh Heydari +17 more

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.006

N/A

0DataRank · unranked

312 citations

Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed +26 more